Filing Flows › Medtronic (MDT) › Capital expenditures
Medtronic (MDT) capital expenditures by quarter
Medtronic's capital expenditures were $503M in Q1 FY27 (first quarter fiscal 2027), +3% from Q4 FY26. Over the last 7 quarters it ranged from $444M (Q3 FY26) to $504M (Q1 FY26).
| Quarter | Capital expenditures | Q/Q | Y/Y |
|---|---|---|---|
| Q1 FY27 | $503M | +3% | -0.2% |
| Q4 FY26 | $488M | +10% | +6% |
| Q3 FY26 | $444M | -5% | -7% |
| Q2 FY26 | $468M | -7% | — |
| Q1 FY26 | $504M | +10% | — |
| Q4 FY25 | $459M | -4% | — |
| Q3 FY25 | $476M | — | — |
Q1 FY27 at a glance
Medtronic, Q1 FY27: revenue $9.8B (+14% year over year), operating margin 18.1%, net earnings $1.5B, operating cash flow $1.8B. The chart follows the revenue to costs, profit and cash.
Questions
What is Medtronic's capital expenditures?
Medtronic's capital expenditures were $503M in Q1 FY27 (first quarter fiscal 2027), +3% from Q4 FY26.
How has Medtronic's capital expenditures changed?
Over the last 7 quarters it ranged from $444M (Q3 FY26) to $504M (Q1 FY26).